(TRENTON) – A Senate panel on Monday
approved legislation sponsored by Assembly Majority Leader Louis Greenwald,
Assemblyman Dan Benson and Assemblywoman Pamela Lampitt aimed at increasing
awareness of ovarian cancer by coordinating efforts on the state level with
those on the national level.
“Ovarian
cancer is one of the deadliest forms of cancer because the symptoms are vague
and non-specific,” said Greenwald (D-Camden/Burlington). “Women and their
physicians often attribute them to more common conditions so by the time the
cancer is diagnosed the tumor has often spread. The best way to combat this is
through awareness and that’s what we hope to accomplish with this
legislation.”
The bill
(A-2161) would change the state designation of “Ovarian Cancer Awareness Month”
from February to September of each year in order to align with the nationwide
observance of September as “National Ovarian Cancer Awareness Month.” The goal
is to promote awareness among the general public and the health care community
of the symptoms of ovarian cancer, the importance of early detection, and the
risk factors associated with developing ovarian cancer.
“Absent
a definitive screening test to detect ovarian cancer, the best way to fight this
disease is by raising public awareness so that it can be recognized and treated
early,” said Benson (D-Mercer/Middlesex). “By coordinating the state’s
awareness efforts with those on the national level, hopefully we can speak
loudly enough in one concerted voice to raise everyone’s awareness of this
silent killer.”
“Having
regular pelvic examinations and increasing public awareness of the risk factors
and health problems associated with ovarian cancer are the best ways to increase
a woman's overall survival rate for this type of cancer,” said Lampitt
(D-Camden/Burlington). “Awareness, in this case, is the best medicine and that
can only be accomplished if we work together to educate women, their families
and their doctors on the signs and symptoms.”
The
lawmakers noted that among women in the United States, ovarian cancer is the
fifth leading cause of cancer death and the eighth most common type of cancer.
While ovarian cancer causes more deaths than any other gynecologic cancer in the
United States, it only accounts for about three percent of all cancers in the
United States.
According to the National Cancer
Institute, it is estimated that 22,280 women will be diagnosed with and 15,500
women will die of ovarian cancer in 2012.
The Centers for Disease Control and Prevention reports that it is estimated that
more than $2.2 billion is spent annually on the treatment of ovarian cancer in
the United States.
Although
all women are at risk for ovarian cancer, older women are more likely to get the
disease with about 90 percent of women who get the disease being 40 years of age
or older and most being 55 years of age or older. Additionally, more than half
the deaths from ovarian cancer occur in women between the ages of 55 and 74 and
approximately one quarter of ovarian cancer deaths occur in women between 35 and
54 years of age.
When
ovarian cancer is found and treated in its earliest stages, the five-year
survival rate is 95 percent. However, most women who suffer from ovarian cancer
are not diagnosed until the later stages of the cancer when the disease has
spread, and the five-year survival rate for these women is 30
percent.
The full
Assembly unanimously approved the measure in October. It now awaits final
legislative approval by the full Senate.
No comments:
Post a Comment